The Journal of Medical Sciences

Register      Login

VOLUME 4 , ISSUE 2 ( April-June, 2018 ) > List of Articles

ORIGINAL ARTICLE

Role of E-cadherin Expression in Breast Carcinoma

AN Dhanya, B Niranjana Murthy

Keywords : Breast carcinoma, E-cadherin, Immunohistochemistry,Bloom Richardson score

Citation Information : Dhanya A, Murthy BN. Role of E-cadherin Expression in Breast Carcinoma. J Med Sci 2018; 4 (2):38-41.

DOI: 10.5005/jp-journals-10045-0082

License: CC BY-SA 4.0

Published Online: 00-06-2018

Copyright Statement:  Copyright © 2018; Jaypee Brothers Medical Publishers (P) Ltd.


Abstract

Introduction: Cancer of breast has emerged as the leading site of cancer in India. E-cadherin (E-CD) is one of calciumdependent transmembrane glycoprotein mediating cell–cell adhesion. It has its application in differentiating invasive ductal carcinoma not otherwise specified (IDC-NOS) vs invasive lobular carcinomas (ILCs) and predicting the aggressiveness of the tumor. In this study, we intend to see E-CD expression in breast carcinoma by immunohistochemistry (IHC), comparing its status with histological grade and type. Materials and methods: A total of 47 breast tissue specimens were included in the study. The histomorphological grading (Modified Scarf Bloom Richardson system) and immunohistochemical scoring were done. Chi-square formula was applied to check the association between E-CD expression and various variables. Results: The mean age was 51 years. The most common type was IDC-NOS (79%) and grade II (38%). Majority (62%) were lymph node negative. The E-CD IHC performed showed most cases (55%) were severely reduced E-CD, while wellexpressed E-CD and moderately reduced E-CD were 28 and 17% respectively. The E-CD expression was statistically significant (p < 0.05) with histological grade and lymph node status. Though the p-value of E-CD expression vs histopathological type was not significant, all ILCs showed complete loss of E-CD expression compared with IDC-NOS. Conclusion: The E-CD expression is well preserved in welldifferentiated carcinomas and reduced in poorly differentiated carcinomas. Loss of E-CD expression is seen in lymph node metastasis breast carcinomas and in high-grade breast carcinomas, which proves E-CD can be used as a marker of tumor invasion and tumor aggressiveness. Complete loss of E-CD is seen in all ILC, which can also be helpful in differentiating IDC NOS from ILC.


PDF Share
  1. Lakhani SR, Ellis OI, Schnitt SJ, Tan PH, Van de Viver MJ (eds). WHO classification of tumours of the breast. 4th ed. Lyon (France): International Agency for Research on Cancer (IARC); 2012.
  2. Malvia S, Bagadi SA, Dubey US, Saxena S. Epidemiology of breast cancer in Indian women. Asia Pac J Clin Oncol 2017 Aug;13(4):289-295.
  3. Lester SC. The breast. In: Kumar V, Abbas A, Aster J (eds). Robbins and Cotran pathologic basics of diseases. South Asian edition. New Delhi: Elsevier; 2015. pp. 1043-1070.
  4. Ahmad Z, Khurshid A, Qureshi A, Idress R, Asghar N, Kayani N. Breast carcinoma grading, estimation of tumor size, axillary lymph node status, staging, and Nottingham prognostic index scoring on mastectomy specimens. Indian J Pathol Microbiol 2009 Oct-Dec;52(4):477-481.
  5. Zaha DC. Significance of immunohistochemistry in breast cancer. World J Clin Oncol 2014 Aug 10;5(3):382-392.
  6. Okegawa T, Pong R-C, Li Y, Hsieh J-T. The role of cell adhesion molecule in cancer progression and its application in cancer therapy. Acta Biochim Pol 2004;51(2):445-457.
  7. Gamallo C, Palacios J, Suarez A, Pizarro A, Navarro P, Quintanilla M, Cano A. Correlation of E-cadherin expression with differentiation grade and histological type in breast carcinoma. Am J Pathol 1993;142(4):987-993.
  8. Singhai R, Patil VW, Jaiswal SR, Patil SD, Tayade MB, Patil AV. E-Cadherin as a diagnostic biomarker in breast cancer. N Am J Med Sci 2011 May;3(5):227-233.
  9. Kashiwagi S, Yashiro M, Takashima T, Nomura S, Noda S, Kawajiri H, Ishikawa T, Wakasa K, Hirakawa K. Significance of E-cadherin expression in triple-negative breast cancer. Br J Cancer 2010 Jul 13;103(2):249-255.
  10. Brzozowska A, Sodolski T, Duma D, Mazurkiewicz T, Mazurkiewicz M. Evaluation of prognostic parameters of E-cadherin status in breast cancer treatment. Ann Agric Environ Med 2012;19(3):541-546.
  11. McCart Reed AE, Kutasovic JR, Lakhani SR, Simpson PT. Invasive lobular carcinoma of the breast: morphology, biomarkers and ’omics. Breast Cancer Res 2015 Jan 30;17(1):12.
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.